🔎 Trials Near Me

Hjem › Brystkreft › New Jersey

Kliniske studier for Brystkreft i New Jersey

93 studier for Brystkreft søker deltakere på steder i New Jersey.

Byer i New Jersey

Offisiell studietekst (engelsk)

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

  • MD Anderson Cancer Center At Cooper, Camden
  • Summit Health, Florham Park
  • The Valley Hospital, Ridgewood
RekruttererFase 3
Alder 18 til 100 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05827081

A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05534438

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Englewood Hospital and Medical Center, Englewood
  • Hackettstown Medical Center, Hackettstown
  • Morristown Medical Center, Morristown
  • og 6 flere
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 40 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05334069

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

  • Astera Cancer Care (Formerly Regional Cancer Care Associates), East Brunswick
  • Medical Oncology Hematology Associates, Newark
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT07102381

A Study of a One-Time Counseling Session to Help Reduce Depression, Anxiety, and Distress in People With Cancer

  • Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Consent Only), Middletown
  • Memorial Sloan Kettering Bergen (Consent Only), Montvale
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07218250

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

  • Research Site, New Brunswick
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT05877599

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

  • John Theurer Cancer Center at Hackensack University Medical Center ( Site 0001), Hackensack
  • Rutgers Cancer Institute of New Jersey ( Site 0033), New Brunswick
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07060807

Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy

  • Cooper Hospital Univ Med Ctr, MD Anderson at Cooper Voorhees, Voorhees Township
Rekrutterer
Alder 30 og eldre · Kvinner · Oppdatert 25. sep. 2026 · NCT02945579

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

  • Hackensack Univ Medical Center (HUMC) ( Site 0007), Hackensack
  • Rutgers Cancer Institute of New Jersey ( Site 0076), New Brunswick
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06966700

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

  • Englewood Hospital, Englewood
  • Capital Health Medical Center - Hopewell, Pennington
  • Penn Medicine - Princeton Health, Plainsboro
RekruttererFase 3
Alder 60 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06377852

A Study of Language Interpretation Solutions for People With Breast Cancer

  • Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Consent Only), Middletown
  • Memorial Sloan Kettering Bergen (Consent Only), Montvale
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06721065

A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
RekruttererFase 1
Alder 18 og eldre · Kvinner · Oppdatert 24. sep. 2026 · NCT05412225

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

  • John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT06618287

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

  • Cooper Health, Camden
  • Rutgers, New Brunswick
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT07214532

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

  • Jefferson Health - Cherry Hill, Cherry Hill
  • Sidney Kimmel Cancer Center - Washington Township, Sewell
  • Atlantic Health System Overlook Medical Center, Summit
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07174336

Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer

  • Memorial Sloan Kettering Basking Ridge, Basking Ridge
  • Memorial Sloan Kettering Monmouth, Middletown
  • Memorial Sloan Kettering Bergen, Montvale
RekruttererFase 2
Alder 45 og eldre · Kvinner · Oppdatert 21. sep. 2026 · NCT04084730

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

  • Summit Medical Group PA, Florham Park
  • Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey), Livingston
  • Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey), Long Branch
  • og 4 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT07173751

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

  • Memorial Sloan Kettering Cancer Center Basking Ridge, Basking Ridge
  • Summit Medical Group, Florham Park
  • Memorial Sloan Kettering Cancer Center Monmouth, Middletown
  • og 1 flere
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT06827236

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

  • MD Anderson Cancer Center at Cooper, Camden
  • Summit Medical Group, Florham Park
  • John Theurer Ctr-Hackensack UMC, Hackensack
  • og 1 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 15. sep. 2026 · NCT06492616

A Study of Pembrolizumab and Ablation (Cryoablation or Histotripsy) in People With Breast Cancer

  • Memorial Sloan Kettering Cancer Center at Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT06246968

A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery

  • Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
RekruttererFase 1/2
Alder 18 og eldre · Kvinner · Oppdatert 11. sep. 2026 · NCT05130801

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

  • START - New Jersey, East Brunswick
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 10. sep. 2026 · NCT06293898

A Phase 1/1b Study of IAM1363 in HER2 Cancers

  • Rutgers Cancer Institute, New Brunswick
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT06253871

A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer

  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge
  • Hackensack Meridian Health, Hackensack
  • Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
  • og 1 flere
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT05570253

To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer

  • Astera Cancer Care East Brunswick, East Brunswick
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 4. sep. 2026 · NCT07368998

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

  • John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
  • Rutgers Cancer Institute, New Brunswick
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 3. sep. 2026 · NCT06982521

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

  • Summit Medical Group, Florham Park
RekruttererObservasjonsstudie
Alder 18 til 99 · Alle kjønn · Oppdatert 3. sep. 2026 · NCT07211178

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

  • Astera Cancer Care East Brunswick, East Brunswick
  • Summit Medical Group, Florham Park
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 3. sep. 2026 · NCT06790693

Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
RekruttererObservasjonsstudie
Alder 18 og eldre · Kvinner · Oppdatert 3. sep. 2026 · NCT05590949

A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors

  • John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 2. sep. 2026 · NCT07287995

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited protocol activities), Montvale
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 2. sep. 2026 · NCT05837767

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

  • Cooper Hospital University Medical Center, Camden
  • Jefferson Cherry Hill Hospital, Cherry Hill
  • Trinitas Hospital and Comprehensive Cancer Center - Williamson Street Campus, Elizabeth
  • og 21 flere
RekruttererFase 3
Alder 18 til 60 · Kvinner · Oppdatert 2. sep. 2026 · NCT05879926

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

  • Hunterdon Medical Center, Flemington
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 2. sep. 2026 · NCT06072612

Study of Aerobic Training for People Receiving Treatment for Breast Cancer

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited protocol activities), Montvale
RekruttererFase 2
Alder 18 og eldre · Kvinner · Oppdatert 27. aug. 2026 · NCT05716893

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

  • START New Jersey, LLC, East Brunswick
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 26. aug. 2026 · NCT07383506

KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer

  • Rutgers Cancer Institute, New Brunswick
  • RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 25. aug. 2026 · NCT05483491

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

  • John Theurer Cancer Ctr at Hackensack Univ. Med Ctr., Hackensack
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 21. aug. 2026 · NCT06774963

HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term Remission

  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering at Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering at Bergen (Limited Protocol Activities), Montvale
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 20. aug. 2026 · NCT07459673

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.